Chembio Diagnostics Reports First Quarter 2020 Financial Results

    NEXT STORY
    Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
    PREV STORY
    Chembio Diagnostics Attains CE Marking for DPP COVID-19 System for IgG and IgM Antibodies
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Phase 2 Results for Madrigal’s MGL-3196 in Non-Alcoholic Steatohepatitis (NASH) Presented during Presidential Plenary Clinical Session of The Liver Meeting® 2018

    -- Statistically significantly more NASH resolution in MGL-3196 as compared with placebo in a ...

    author_avatar
    NASDAQ Market News

    Project HOPE and Boeing Team Up to Boost Maternal and Newborn Care in Hungary

    MILLWOOD, Va., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Project HOPE and Boeing are teaming ...

    author_avatar
    NASDAQ Market News

    TRACON Pharmaceuticals Announces Top-line Results from NCI-Sponsored Phase 2 Trial of TRC105 in Recurrent Glioblastoma

    Combination of TRC105 and Avastin did not improve the median progression free survival versus ...

    author_avatar
    NASDAQ Market News